FUNDRAISING FOR A CURE
Donating is simple, fast and totally secure. Your details are safe with us and we will never sell them
Pancreatic Cancer UK is delighted to announce NHS England has referred the development of a pancreatic cancer Clinical Guideline and Quality Standard to the National Institute for Health and Care Excellence (NICE). This represents very good news for pancreatic cancer in a week where new statistics show just 1% of pancreatic cancer patients are expected to survive 10 years.
The lack of updated NICE guidelines for pancreatic cancer has been a key platform of Pancreatic Cancer UK’s lobbying activity since the publication of its 2011 “Study for Survival” report and the launch of its flagship “Campaign for Hope”. The campaign aims to double five-year survival rates within five years and to move the NHS experience of pancreatic cancer patients from one of the worse to one of the best.
This new guideline for pancreatic cancer is expected to positively impact on patient experience and treatment in secondary care. For example, it is likely to provide direction on the most up-to-date and effective surgical, oncological approaches as well as interventions such as radiotherapy. We also expect it to include guidance on well-being, nutrition and diet related issues.
Alex Ford, Chief Executive of Pancreatic Cancer UK, comments, “These new guidelines have the potential to ensure that the treatment and care of all pancreatic cancer patients is in line with the most up to date evidence about best practice and is of the highest standard possible. In our view this is the most important and exciting development in pancreatic cancer since the publication of the Improving Outcomes Guidance nearly 15 years ago.”
Sean Duffy, National Clinical Director for Cancer for NHS England, adds “The development of clinical guidelines for pancreatic cancer is long overdue. I am delighted that NICE will be taking on this task, and very hopeful that it will result in improved treatment and care for a group of patients whose experience of the NHS, as we know from the Cancer Patient Experience Survey, remains one of the worst.”
The NICE timeline for the development of these guidelines is yet to be confirmed. However, it is anticipated that the process will start late 2014 or early 2015.
For further information contact:
Louise Ellis, Communications Manager, Pancreatic Cancer UK
020 7820 6709 / 07584 293 039
READ ABOUT HOW FUNDS ARE USED
PLANETS completes £1 million fundraising campaign to purchase pioneering radiotherapy machine
PLANETS has thanked its supporters after completing a £1 million fundraising campaign and making the final payment for a pioneering radiotherapy machine. PLANETS Cancer Charity has been fundraising for the past six years to fully purchase Mobetron, a revolutionary mobile device which delivers radiotherapy during surgery – known as intraoperative radiotherapy (IORT). When the charity […]
PLANETS Receive £10,000 Grant from The Hospital Saturday Fund
Thank you to John Greenwood, Trustee of the The Hospital Saturday Fund, for visiting us on Monday and bringing this incredible grant of £10,000 to support our IORT (Intra Operative Radiotherapy) machine. This will enable us to continue delivering this lifesaving treatment at University Hospital Southampton – the only centre in the UK currently offering […]
PLANETS Fund ‘New View’ Psychotherapy Course for NET Patients
PLANETS have funded a psychotherapy programme, after a successful pilot course, to help NET patients see their diagnosis in a ‘new view’. We all know that different people deal with their neuroendocrine cancer diagnosis very differently. Initially there are lots of scary tests and Doctor appointments. Then there are lots of talk about […]
Head and Neck Cancer Patient Treated with IORT in UK First
A woman from Salisbury has become the first patient in the UK with head and neck cancer to receive radiotherapy in the operating theatre during surgery to remove a recurrent tumour. Jayne Garrett, 53, underwent major surgery at University Hospital Southampton on 25 April after suffering a recurrence of her cancer following conventional treatment […]
PLANETS Host the 1st National IORT Symposium
It was an honour to present the fantastic work and great initial results to medics from all over the country at our 1st National IORT (intra-operative radiotherapy) Symposium on Friday June 21st at University Hospital Southampton. After a lot of hard work and fundraising in order to bring IORT to the UK for the […]
PLANETS Cancer Charity and the Robert White Trust, Fund a new regional NET Cancer Dietitian
A dietitian funded by PLANETS Cancer Charity and the Robert White Trust Fund is due to start work to develop and provide a comprehensive dietetic service to patients diagnosed with Neuroendocrine Cancer (NETs). Ruth Lee will be based at the Dorset NET service, which is part of the Wessex European Neuroendocrine tumour society centre […]
Southampton Secure £200k from The Robert White Trust for NETs Research
PLANETS are excited to share the news that University Hospital Southampton have secured £200,000 funding from the Robert White Trust for a research project that aims to gain a better understanding of NET biology which may lead to a greater range of treatment options for patients with this rare disease. Robert White was a former […]
Bowel cancer patient becomes first in UK to be treated with IORT
We are thrilled and proud to update our supporters that a Southampton bowel cancer patient has become the first in the UK to receive radiotherapy during surgery using the IORT machine that PLANETS has funded. he 58-year-old male, who completed a combination of conventional chemotherapy and radiotherapy in August, underwent major surgery at Southampton […]
IORT Launch is a Success!
SOUTHAMPTON CLINICIANS PIONEER USE OF REVOLUTIONARY CANCER DEVICE PLANETS founders Neil Pearce and Brian Stedman, together with fund manager Layla Stephen successfully launched our long awaited IORT machine last night. The Mobetron is the first portable system able to administer the treatment in this way – known as intraoperative radiotherapy (IORT) – and will […]
IORT Arrives at Southampton!
PLANETS are thrilled to announce that the eagle (finally) has landed! 2 tons of intra-operative radio-therapy machine (IORT) arrived from the USA this week – currently undergoing acceptance testing. This is the UK’s first ever mobile electron beam radiotherapy machine for treating cancers during surgery. Thanks to everyone who has supported our fundraising which has […]
Southampton Aiding Research into Earlier Diagnosis for Pancreatic Cancer
You may have notice that Southampton was mentioned in recent media stories regarding The National Tumour Bank that is carrying out important pancreatic cancer research? Colin Johnson, Professor of Surgical Sciences at University of Southampton, has this to say about the project: ‘The National Tissue Bank is a major development in pancreatic cancer research. Several […]
Sainsbury’s Hedge End Donate Digital Radios
A big thank you to Sainsbury’s Hedge End for donating two digital radios to PLANETS to be used in the lead lined Gamma Scanner Rooms at Southampton General. Pictured presenting the radios to staff in the scanner rooms are PLANETS Fund Manager, Layla Stephen, and Dr Brian Stedman.
PLANETS to Fund Pancreatic Cancer Research at Southampton
PLANETS Charitable Fund are excited to have committed to provide a grant over a two year period for a pancreatic research project: ́The role of Eps8 in αvβ6-dependent functions in pancreatic cancer invasion’ to be undertaken by Dr Jo Tod. Pancreatic adenocarcinoma (PC) has one of the worst outcomes of any cancer; only 3.7% of patients […]
First Patient Receives PRRT at Southampton thanks to PLANETS
[social_button button=”facebook” flayout=”standard ” fwidth=”450″ faction=”like” fcolorsheme=”light”] UHS magazine Connect featured a fantastic article about NET patient Maureen McKenzie who, in July 2013, became the first Southampton patient to receive PRRT (peptide receptor radionuclide therapy). The equipment for this treatment was jointly funded by UHS and PLANETS showing just how important and valuable the […]
Improving Patient Services Across the Region
[social_button button=”facebook” flayout=”standard ” fwidth=”450″ faction=”like” fcolorsheme=”light”] Pancreatic cancer affects over 8000 patients each year in the uk and remains the fifth biggest cancer killer in the UK, despite this its has been underfunded for many years and currently receives just 1% of total cancer research funding in the UK. NETs are a rare form […]
Subscribe to our Newsletter
Get informed about the latest news straight to your inbox